145 related articles for article (PubMed ID: 16764642)
1. Sudden hearing loss associated with tacrolimus in a liver transplant recipient.
Norman K; Bonatti H; Dickson RC; Aranda-Michel J
Transpl Int; 2006 Jul; 19(7):601-3. PubMed ID: 16764642
[No Abstract] [Full Text] [Related]
2. Recurrence of migraine with aura due to tacrolimus therapy in a liver transplant recipient successfully treated with sirolimus substitution.
Toth CC; Burak K; Becker W
Headache; 2005 Mar; 45(3):245-6. PubMed ID: 15836601
[TBL] [Abstract][Full Text] [Related]
3. Severe hearing loss after liver transplantation.
Rifai K; Bahr MJ; Cantz T; Klempnauer J; Manns MP; Strassburg CP
Transplant Proc; 2005 May; 37(4):1918-9. PubMed ID: 15919504
[TBL] [Abstract][Full Text] [Related]
4. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
5. Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens.
DuBay D; Smith RJ; Qiu KG; Levy GA; Lilly L; Therapondos G
Liver Transpl; 2008 May; 14(5):651-9. PubMed ID: 18433069
[TBL] [Abstract][Full Text] [Related]
6. Sirolimus-based immunosuppressive therapy in liver transplant recipient with tacrolimus-related chronic renal insufficiency.
Yang YJ; Chen DZ; Li LX; Kou JT; Lang R; Jin ZK; Han DD; He Q
Transplant Proc; 2008 Jun; 40(5):1541-4. PubMed ID: 18589147
[TBL] [Abstract][Full Text] [Related]
7. Late-onset tacrolimus-associated cerebellar atrophia in a heart transplant recipient.
Kaczmarek I; Schmauss D; Sodian R; Beiras-Fernandez A; Oberhoffer M; Daebritz S; Schoenberg SO; Reichart B
J Heart Lung Transplant; 2007 Jan; 26(1):89-92. PubMed ID: 17234523
[TBL] [Abstract][Full Text] [Related]
8. Catatonic mutism after liver transplant rapidly reversed with lorazepam.
O'Donnell MM; Williams JP; Weinrieb R; Denysenko L
Gen Hosp Psychiatry; 2007; 29(3):280-1. PubMed ID: 17484951
[No Abstract] [Full Text] [Related]
9. Sudden hearing loss associated with tacrolimus in a kidney-pancreas allograft recipient.
Min DI; Ku YM; Rayhill S; Corwin C; Wu YM; Hunsicker LG
Pharmacotherapy; 1999 Jul; 19(7):891-3. PubMed ID: 10417040
[TBL] [Abstract][Full Text] [Related]
10. Bradycardia associated with intravenous administration of tacrolimus in a liver transplant recipient.
Cox TH; Baillie GM; Baliga P
Pharmacotherapy; 1997; 17(6):1328-30. PubMed ID: 9399620
[TBL] [Abstract][Full Text] [Related]
11. Sudden hearing loss associated with tacrolimus after pediatric renal transplant.
Gulleroglu K; Baskin E; Bayrakci U; Aydin E; Ozluoglu L; Moray G; Haberal M
Exp Clin Transplant; 2013 Dec; 11(6):562-4. PubMed ID: 24344948
[TBL] [Abstract][Full Text] [Related]
12. Development of multiple food allergies in children taking tacrolimus after heart and liver transplantation.
Ozdemir O; Arrey-Mensah A; Sorensen RU
Pediatr Transplant; 2006 May; 10(3):380-3. PubMed ID: 16677366
[TBL] [Abstract][Full Text] [Related]
13. Post-transplant diabetes mellitus in liver transplantation: Hangzhou experience.
Xu X; Ling Q; He ZL; Gao F; Zheng SS
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):465-70. PubMed ID: 18842490
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function.
Watson CJ; Gimson AE; Alexander GJ; Allison ME; Gibbs P; Smith JC; Palmer CR; Bradley JA
Liver Transpl; 2007 Dec; 13(12):1694-702. PubMed ID: 18044728
[TBL] [Abstract][Full Text] [Related]
15. Sirolimus conversion for renal preservation in liver transplantation: not so fast.
Jensen GS; Wiseman A; Trotter JF
Liver Transpl; 2008 May; 14(5):601-3. PubMed ID: 18433068
[No Abstract] [Full Text] [Related]
16. [The prevention and management of cerebrovascular complications in nine cases after orthotopic liver transplantation].
Qian SK; He XS; Zhu XF; Ma Y; Wang DP; Ju WQ; Wu LW; Zhang XL; Yu XB
Zhonghua Gan Zang Bing Za Zhi; 2005 Nov; 13(11):860-1. PubMed ID: 16313741
[No Abstract] [Full Text] [Related]
17. Sirolimus as primary immunosuppressant for calcineurin inhibitor-related renal insufficiency after liver transplantation.
Yang YJ; Li LX; He Q; Fan H; Jin ZK; Lang R; Kou JT; Li P; Xie DH; Chen DZ
Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):376-8. PubMed ID: 17690032
[TBL] [Abstract][Full Text] [Related]
18. Fatty liver due to high levels of serum tacrolimus after liver transplantation.
Tümgör G; Ankan C; Nart D; Kihiç M; Aydoğdu S
Turk J Pediatr; 2007; 49(2):223-5. PubMed ID: 17907528
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus and food allergy.
Pacifico L; Frediani T; Simonetti A; Chiesa C; Cucchiara S
Transplantation; 2003 Dec; 76(12):1778. PubMed ID: 14688538
[No Abstract] [Full Text] [Related]
20. Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients.
Fukudo M; Yano I; Yoshimura A; Masuda S; Uesugi M; Hosohata K; Katsura T; Ogura Y; Oike F; Takada Y; Uemoto S; Inui K
Pharmacogenet Genomics; 2008 May; 18(5):413-23. PubMed ID: 18408564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
